EAR Eargo, Inc.

Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.

$37.51  -0.43 (-1.13%)
As of 06/24/2021 15:59:53 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  10/16/2020
Outstanding shares:  38,731,538
Average volume:  533,504
Market cap:   $1,453,207,306
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    270087109
ISIN:        US2700871096
Sedol:      BNGFSB6

---

Valuation   (See tab for details)

---

PE ratio:   -33.54
PB ratio:   7.91
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%